Advertisement

Pädiatrie pp 684-690 | Cite as

Systemischer Lupus erythematodes und seltene rheumatische Erkrankungen (Mixed connective tissue disease, Sjögren-Syndrom, eosinophile Fasziitis)

  • N. Wagner
  • G. Dannecker

Auszug

Definition. Der systemische Lupus erythemathodes (SLE) ist eine B-Zell-vermittelte, chronisch-entzündliche Autoimmunkrankheit, die gekennzeichnet ist durch Produktion von Autoantikörpern gegen Zellkernbestandteile und Ablagerung von Immunkomplexen, die eine Vaskulitis verursachen. Zahlreiche Organe wie z. B. Haut, Niere, Lunge und ZNS können betroffen sein. Die Erstbeschreibung des SLE als Systemerkrankung erfolgte durch Kaposi 1872 (Abb. 87.1 , 87.2).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bader-Meunier B, Armengaud JB, Haddad E et al. (2005) Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 146:648–653.CrossRefPubMedGoogle Scholar
  2. Baqi N, Moazami S, Singh A et al. (1996) Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7: 924–929PubMedGoogle Scholar
  3. Benseier SM, Silverman ED (2005) Systemic lupus erythematosus. Pediatr Clin North Am 52: 443–467CrossRefGoogle Scholar
  4. Buyon JP, Clancy R (2003) Neonatal lupus syndromes. Curr Opin Rheumatol 15: 535–541CrossRefPubMedGoogle Scholar
  5. Cassidy JT, Petty RE (2005) Textbook of pediatric rheumatology, 5th edn. Saunders, PhiladelphiaGoogle Scholar
  6. Chan TM, Tse KC, Tang CS et al. (2005) Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16:1076–1084CrossRefPubMedGoogle Scholar
  7. Contreras G, Pardo V, Leclercq et al. (2004) Sequential therapies for proliferative lupus nephritis. N Engl 350: 971–980CrossRefGoogle Scholar
  8. Hahn BH (1998) Antibodies to DNA. N Engl J Med 338:1359–1368CrossRefPubMedGoogle Scholar
  9. Kotzin BL (1996) Systemic lupus erythematosus. Cell 85: 303–306CrossRefPubMedGoogle Scholar
  10. Lee T, Scheven E von, Sandborg C (2001) Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 13: 415–421CrossRefPubMedGoogle Scholar
  11. Lehman TJA, Onel K (2000) Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136: 243–247CrossRefPubMedGoogle Scholar
  12. Lehman TJA, Edelheit BS, Onel KB (2004) Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis 63: 321–323CrossRefPubMedPubMedCentralGoogle Scholar
  13. Rosenberg AM (1994) Systemic lupus erythematosus in children. Springer Sem Immunopathol 16: 261–279CrossRefGoogle Scholar
  14. Scheven E von, Athreya BH, Rose CD, Goldsmith DP, Morton L (1996) Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 129: 339–345CrossRefGoogle Scholar
  15. Wakeland EK, Liu K, Graham RR et al. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15: 397–408CrossRefPubMedGoogle Scholar
  16. Weening JJ, D’Agati VD, Schwartz MM et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241–250CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2007

Authors and Affiliations

  • N. Wagner
    • 1
  • G. Dannecker
    • 2
  1. 1.Klinik für Kinder- und Jugendmedizin der RWTH AachenAachenGermany
  2. 2.Pädiatrisches ZentrumStuttgartGermany

Personalised recommendations